［1］AAP Subcommittee on Neonatal Hyperbilirubinemia. Neonatal jaundice and kernicterus［J］. Pediatrics, 2001, 108(3): 763-765.
［2］Penn AA, Enzmann DR, Hahn JS, Stevenson DK. Kernicterus in a full term infant［J］. Pediatrics, 1994, 93(6 Pt 1): 1003-1006.
［3］Maisles MJ, Newman TB. Kernicterus in otherwise healthy, breast-fed term newborns［J］. Pediatrics, 1995, 96(4 Pt 1): 730-733.
［4］Centers for Disease Control and Prevention (CDC). Kernicterus in a full term infant--United States, 1994-1998［J］. MMWR Morb Mortal Wkly Rep, 2001, 50(23): 491-494.
［5］Maisels MJ, Newman TB. Jaundice in full-term and near-term babies who leave the hospital within 36 hours. The pediatricians nemesis［J］. Clin Perinatol, 1998, 25(2): 295-302.
［6］American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks gestation.［J］. Pediatrics, 2004, 114(1): 297-316.
［7］Canadian Pediatric Society. Canadian Pediatric Surveillance Program 2004 Results ［DB/OL］. Available at www.cps.ca.
［9］Soorani-Lunsing I, Woltil HA, Hadders-Algra M. Are moderate degrees of hyperbilirubinema in healthy term neonates really safe for the brain?［J］. Pediatr Res, 2001, 50(6): 701-705.
［11］Newman TB, Maisels MJ. Evaluation and treatment of jaundice in term newborns: a kinder, gentler approach［J］. Pediatrics, 1992, 89(5 Pt 1): 809-818.
［12］Volpe JJ. Neurology of the Newborn［M］. 4th ed. Philadelphia PA: WB Saunders, 2001.
［13］Ohlsson A. Neonatal jaundice: continuing concern and need for research［J］. Pediatr Res, 2001, 50(6): 674-675.
［14］Hintz SR, Stevenson DK. Just when you thought it was safe［J］. Pediatr Res, 2001, 50(6): 676-677.
［15］Ip S, Chung M, Kulig J, O′Brien, Sege R, Glicken S, et al. An evidence-based review of important issues concerning neonatal hyperbilirubinemia［J］. Pediatrics, 2004, 114(1): e130-e153.
［16］Johnson LH, Bhutani VK, Brown AK. System-based approach to management of neonatal jaundice and prevention of kernicterus［J］. J Pediatr, 2002, 140(4): 396-403.
［17］Stevenson DK, Fanaroff AA, Maisels MJ, Young BW, Wong RJ, Vreman HJ, et al. Prediction of hyperbilirubinemia in near-term and term infants［J］. Pediatrics, 2001, 108(1): 31-39.
［18］Bhutani VK, Gourley GR, Adler S, Kreamer B, Dalin C, Johnson LH. Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia［J］. Pediatrics, 2000, 106(2): E17.
［19］Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns［J］. Pediatrics, 1999, 103(1): 6-14.
［21］Rubaltelli FF, Gourley GR, Loskamp N, Modi N, RothKleiner M, Sender A, et al. Transcutaneous bilirubin measurement: a multicenter evaluation of a new device［J］. Pediatrics, 2001, 107(6): 1264-1271.
［22］Leslie GI, Philips JB, Cassady G. Capillary and venous bilirubin values. Are they really different?［J］. Am J Dis Child, 1987, 141(11): 1199-1200.
［23］Ciemer RJ, Perryman PW, Richards DH. Influence of light on the hyperbilirubinemia of infants［J］. Lancet, 1958, 1(7030): 1094-1097.
［24］Rubaltelli FF, Carli M. The effect of light on cutaneous bilirubin［J］. Biol Neonate, 1971, 18(5): 457-462.
［25］Bhutani VK, Johnson LH. Jaundice technologies: prediction of hyperbilirubinemia in term and near-term newborns［J］. J Perinatol, 2001, 21(Suppl 1): S76-S82.
［26］Halamek LP, Stevenson DK. Neonatal jaundice and liver disease［M］// Fanaroff AA, Martin RJ. Neonatal Perinatal Medicine: Diseases of the Fetus and Newborn. 7th ed. Saint Louis: Mosby, 2002: 1345-1372.
［27］Sisson TR, Kendall N, Shaw E, Kechavarz-Oliai L. Phototherapy of jaudice in the newborn infant Ⅱ. Effect of various light intensities［J］. J Pediatr, 1972, 81(1): 35-38.
［28］Wzrshaw JB, Gagliardi J, Patel A. A comparison of fluorescent and nonfluorescent light sources for phototherapy［J］. Pediatrics, 1980, 65(4): 795-798.
［29］Vogl TP. Phototherapy of neonatal hyperbilirubinemia: bilirubin in unexposed areas of the skin［J］. J Pediatr, 1974, 85(5): 707-710.
［30］Seidman DS, Moise J, Ergaz Z, Laor A, Vreman HJ, Stevenson DK, et al. A new blue light-emitting phototherapy device: a prospective randomized controlled study［J］. J Pediatr, 2000, 136(6): 771-774.
［31］Mills JF, Tudehope D. Fiberoptic therapy for neonatal jaundice. The Cochrane Systematic Review, 2001, (1): CD002060.
［32］Brown AK, Kim MH, Wu PY, Bryla DA. Efficacy of phototherapy in prevention and management of neonatal hyperbilirubinemia［J］. Pediatrics, 1985, 75(2 Pt 2): 393-400.
［33］Sarici SU, Serdar MA, Korkmaz A, Erdem G, Oran O, Tekinalp G, et al. Incidence, course, and prediction of hyperbilirubinemia in near-term and term newborns［J］. Pediatircs, 2004, 113(4): 775-780.
［34］Newman TB, Liljestrand P, Escobar GJ. Combining clinical risk factors with serum bilirubin levels to predict hyperbilirubinemia in newborns［J］. Arch Pediatr Adolesc Med, 2005, 159(2):113-119.
［35］Rübo J, Albrecht K, Lasch P, Laufk-tter E, Leititis J, Marsan D, et al. High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease［J］. J Pediatr, 1992, 121(1):93-97.
［36］Kappas A, Drummond GS, Valaes T. A single dose of Sn-mesoporphyrin prevents development of severe hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns［J］. Pediatrics, 2001, 108(1):25-30.
［37］Maisels MJ, Gifford K. Breast-feeding, weight loss, and jaundice［J］. J Pediatr, 1983, 102(1): 117-118.
［38］Lawrence RA. Management of mother-infant nursing couple［M］// Breastfeeding--A Guide for the Medical Profession. 4th ed, St. Louis MO: Mosby Yearbook INC, 1994:215-277.
［39］Butler DA, MacMillan JP. Relationship of breast feeding and weight loss to jaundice in the newborn period: review of the literature and results of a study［J］. Cleve Clin Q, 1983, 50(3): 263-268.
［40］Nicoll A, Ginsburg R, Tripp JH. Supplementary feeding and jaundice in newborns［J］. Acta Pediatr Scand, 1982, 71(5): 759-761.
